FDA
Potassium Chloride
The FDA lists this product in 60 strengths and forms.
Indications
Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.
( 1 )
Contraindications
Potassium chloride is contraindicated in patients on potassium sparing diuretics. Concomitant use with potassium sparing diuretics. ( 4 )
Warnings and precautions
- Gastrointestinal Irritation : Dilute before use, take with meals ( 5.1 )
5.1Gastrointestinal Irritation
May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration ( 2.1 )].
Interactions
Potassium sparing diuretics: Avoid concomitant use ( 7.1 ) Renin-Angiotensin-Aldosterone Inhibitors: Monitor for hyperkalemia ( 7.2 ) Nonsteroidal Anti-Inflammatory Drugs: Monitor for hyperkalemia ( 7.3 )
7.1Potassium-Sparing Diuretics Use
with potassium-sparing diuretic can produce severe hyperkalemia. Avoid concomitant use.
7.2Renin-Angiotensin-Aldosterone System Inhibitors
Drugs that inhibit the renin-angiotensin-aldosterone System (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production. Closely monitor potassium in patients receiving concomitant RAAS therapy.
7.3
At a glance
- Brand name
- Potassium Chloride
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Pharm Assoc
- Status
- Prescription
- FDA approval
- 29 Mar 2019
- Application
- ANDA210766-002



